Rhythm Pharmaceuticals
RYTM
RYTM
90 hedge funds and large institutions have $191M invested in Rhythm Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-21
Holders Change %
-18.92%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
23
Reduced
31
Closed
36
Calls
$1.67M
Puts
$120K
Net Calls
+$1.55M
Net Calls Change
-$2.4M
Top Buyers
| 1 |
1
Alkeon Capital Management
New York
|
$6.23M |
| 2 |
2
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.57M |
| 3 |
OM
3
Opaleye Management
Boston,
Massachusetts
|
$1.5M |
| 4 |
E
4
Ergoteles
New York
|
$883K |
| 5 |
5
Morgan Stanley
New York
|
$1.79M |
